Publication | Closed Access

PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib

ChromatinDevelopmental BiologyMendelian DisorderOvergrowth SyndromeMedicineGenetic DisorderFamilial Infantile MyofibromatosisPathologyPdgfrb MutantsMolecular DiagnosticsCell BiologyTumor BiologyMyeloid Neoplasia